Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food Effect Study of DDO-3055 in Healthy Subjects
NCT04197778Phase 1Completed
- Sponsor
- Hengrui
- Start
- Jan 2020
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of DDO-3055 in anemia of chronic kidney disease (CKD-A) (2 arms), sponsored by Hengrui. Primary endpoints: Area under the concentration-time curve up to 2 days, Maximum plasma concentration up to 2 days and 4 more. Started Jan 2020; status: completed.
02
Drugs
DDO-3055
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT04197778.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04197778.